A Preliminary Investigation of the Efficacy of Aromatherapy in Reducing Discomfort in Youth With Chronic Headache
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02440997 |
Recruitment Status :
Completed
First Posted : May 12, 2015
Last Update Posted : April 10, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Chronic Headache Migraine Headache Headache | Other: aromatherapy Other: foot bath | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 46 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Treatment |
Official Title: | A Preliminary Investigation of the Efficacy of Aromatherapy in Reducing Discomfort in Youth With Chronic Headache |
Actual Study Start Date : | March 25, 2015 |
Actual Primary Completion Date : | January 4, 2017 |
Actual Study Completion Date : | January 4, 2017 |

Arm | Intervention/treatment |
---|---|
Placebo Comparator: foot bath only
10 minute foot bath with addition of jojoba only
|
Other: foot bath |
Experimental: foot bath and aromatherapy
10 minute foot bath with addition of jojoba with added Mentha piperita
|
Other: aromatherapy
Other Name: Mentha piperita Other: foot bath |
- improvement in subjective and objective indicators of discomfort [ Time Frame: 30 minutes ]pain and anxiety measured subjectively via VAS
- improvement in subjective and objective indicators of discomfort [ Time Frame: 30 minutes ]heart rate variability measured -10, 10 and 20 minutes
- number of Adverse Events [ Time Frame: 30 minutes ]assessment of presence or absence of Adverse Events or Serious Adverse Events

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 7 Years to 17 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
-
• Male or female, children and adolescents age 7-17 years of age
- Diagnosed with status migrainosus or refractory chronic daily headache according to the International Headache Society (ICHD-II) criteria. (A debilitating migraine lasting for more than 72 hours or a headache that lasts hours or may be continuous occurring on > 15 days per month for > 3 months.)
- No prior history of aromatherapy / essential oil use
- Able to read, comprehend and complete study procedures. Capable of reading and completing all subjective measures in English
- Are sufficiently alert to be assessed and communicate
- Must be compliant with routine medical care and able to perform study-related procedures
- Provide written informed consent from parent/legal guardian and child assent in accordance with IRB regulations
Exclusion Criteria:
-
• Known sensitivity to essential oils
- History of cardiac fibrillation
- History of G6PD deficiency
- History of uncontrolled asthma (current, active wheezing)
- History of diabetes, high blood pressure, epilepsy,
- Inflammatory or sensory limitations of lower extremities or concurrent lesions of the foot(s)
- Past or concurrent history of olfactory impairment
- Concomitant use of propanolol
- Tobacco use
- Hepatotoxicity
- Pregnancy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02440997
United States, Missouri | |
Children's Mercy Hospital | |
Kansas City, Missouri, United States, 64108 |
Principal Investigator: | Rae A Kingsley, MSN, APRN | Children's Mercy Hospital Kansas City |
Publications:
Responsible Party: | Children's Mercy Hospital Kansas City |
ClinicalTrials.gov Identifier: | NCT02440997 |
Other Study ID Numbers: |
IRB # 15010015 |
First Posted: | May 12, 2015 Key Record Dates |
Last Update Posted: | April 10, 2017 |
Last Verified: | April 2017 |
aromatherapy, peppermint |
Migraine Disorders Headache Disorders Headache Pain Neurologic Manifestations |
Headache Disorders, Primary Brain Diseases Central Nervous System Diseases Nervous System Diseases |